Literature DB >> 32453692

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.

Marco Cattaneo1,2, Nuccia Morici3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32453692      PMCID： PMC7250693          DOI： 10.2450/2020.0109-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

1.  COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).

Authors:  Marco Marietta; Walter Ageno; Andrea Artoni; Erica De Candia; Paolo Gresele; Marina Marchetti; Rossella Marcucci; Armando Tripodi
Journal:  Blood Transfus       Date:  2020-04-08       Impact factor: 3.443

2.  Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.

Authors:  Tao Wang; Ruchong Chen; Chunli Liu; Wenhua Liang; Weijie Guan; Ruidi Tang; Chunli Tang; Nuofu Zhang; Nanshan Zhong; Shiyue Li
Journal:  Lancet Haematol       Date:  2020-04-09       Impact factor: 18.959

3.  Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

Authors:  Marco Cattaneo; Elena M Bertinato; Simone Birocchi; Carolina Brizio; Daniele Malavolta; Marco Manzoni; Gesualdo Muscarella; Michela Orlandi
Journal:  Thromb Haemost       Date:  2020-04-29       Impact factor: 5.249

4.  Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.

Authors:  Yingzhen Du; Lei Tu; Pingjun Zhu; Mi Mu; Runsheng Wang; Pengcheng Yang; Xi Wang; Chao Hu; Rongyu Ping; Peng Hu; Tianzhi Li; Feng Cao; Christopher Chang; Qinyong Hu; Yang Jin; Guogang Xu
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

5.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26
  5 in total
  3 in total

1.  Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".

Authors:  Marco Marietta; Armando Tripodi
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

2.  Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.

Authors:  Pierpaolo Di Micco; Vincenzo Russo; Corrado Lodigiani
Journal:  Medicina (Kaunas)       Date:  2020-09-27       Impact factor: 2.430

3.  Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic).

Authors:  Marcela P Vizcaychipi; Claire L Shovlin; Alex McCarthy; Andrew Godfrey; Sheena Patel; Pallav L Shah; Michelle Hayes; Richard T Keays; Iain Beveridge; Gary Davies
Journal:  Braz J Infect Dis       Date:  2020-08-18       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.